Page 47 - Diagnostics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT ... | June 18, 2023

Needham & Company LLC reissued their buy rating on shares of Lucid Diagnostics (NASDAQ:LUCD – Get Rating) in a report published on Friday, Benzinga reports. The firm currently has a $2.60 price target on the stock. Lucid Diagnostics Stock Down 1.9 % Shares of NASDAQ:LUCD opened at $1.53 on Friday. The firm has a market […]

Zevra Therapeutics (NASDAQ:ZVRA – Get Rating) and ERBA Diagnostics (OTCMKTS:ERBA – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, analyst recommendations and dividends. Analyst Ratings This is a summary of current ratings for […]

Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating)’s share price fell 4% on Friday . The stock traded as low as $1.45 and last traded at $1.45. 64,562 shares traded hands during mid-day trading, a decline of 52% from the average session volume of 135,768 shares. The stock had previously closed at $1.51. Analysts Set New Price […]

Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Rating) was the recipient of a large decline in short interest in March. As of March 31st, there was short interest totalling 4,760,000 shares, a decline of 6.1% from the March 15th total of 5,070,000 shares. Based on an average daily volume of 293,900 shares, the short-interest ratio is […]